baber/WOPTO huggingface dataset:
Patent AU-2019344667-A1 (AU)
Title: Techniques for search space management
Inventor: CHAKRABORTY KAUSHIK
IPC: H04B7/0408
Filed: 2019-09-16
Abstract: Methods, systems, and devices for using a common physical downlink control channel (PDCCH) to indicate transmission beams to be used by a base station during a transmission opportunity or a periodicity to monitor search spaces are described. A user equipment (UE) may monitor a search space (in some cases, using a periodicity) for the common PDCCH to determine if transmission beams associated with the UE are to be used during the transmission opportunity. If so, the UE may wake-up during at least a portion of the transmission opportunity to receive additional information. If the common PDCCH indicates that no transmission beams associated with the UE are to be used during the transmission opportunity, the UE may enter or re-enter the sleep state. The UE may switch to a new periodicity for monitoring the search space based on the information transmitted within the common PDCCH.
Patent AU-2019362347-A1 (AU)
Title: Image processing method and apparatus, and device
Inventor: LI YU
IPC: G06T7/11
Filed: 2019-06-18
Abstract: Provided is an image processing method. By performing template segmentation on an image, a target area and a background area are determined within the image; by applying different color processing methods to the target area and the background area, the brightness or chrominance of the target area is higher than the brightness and chrominance of the background area, such that the theme corresponding to the target area is more prominently highlighted, thereby realizing movie effects when a terminal user photographs a picture or a video, and improving the user's photographing experience. In addition, also provided is a method for confirming a target area in different time periods and changing a color processing mode in different time periods, so that the theme change and the color change of video content are more flexible and autonomous, and human-computer interaction is enhanced.
Patent AU-2019362600-A1 (AU)
Title: Beverage-preparation machine
Inventor: DÜNKI CHRISTIAN
IPC: A47J31/46
Filed: 2019-10-17
Abstract: The beverage-preparation machine has a pump (5) for pumping the preparation liquid, generally water, into a brewing chamber which receives the portion pack (20) and a flow meter (3) for measuring the flow of liquid into the brewing chamber. An electronic machine unit (9) controls the pump (5) and detects the results of the flow measurement in order to deactivate the pump after a specified amount of liquid has been pumped for example. According to one aspect of the invention, the electronic unit (9) is designed to analyze the measured flow and draw a distinction between a first state, "brewing with inserted portion pack," and a second state, "water flow without an inserted portion pack," in order to detect the presence of a portion pack (20) in the brewing chamber.
Patent AU-2019373059-A1 (AU)
Title: 2-azabicyclo hexane compound as JAK inhibitor
Inventor: FATHEREE PAUL R
IPC: A61P27/02
Filed: 2019-10-18
Abstract: The invention provides a compound of formula 1 or a pharmaceutically-acceptable salt thereof, that is useful as a JAK inhibitor. The invention also provides pharmaceutical compositions comprising the compound, methods of using the compound to treat diseases amenable to a JAK inhibitor, and processes useful for preparing the compound.
Patent AU-2019387212-A1 (AU)
Title: Methods of treating conditions related to the S1P1 receptor
Inventor: NAIK SNEHAL
IPC: A61K31/404
Filed: 2019-11-26
Abstract: Provided is a method of determining if an individual is a responder to treatment with (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid (Compound 1) or a pharmaceutically acceptable salt, solvate or hydrate thereof.
Patent AU-2019387329-A1 (AU)
Title: Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component
Inventor: SPECKMANN BODO
IPC: A61K9/127
Filed: 2019-11-28
Abstract: The invention relates to preparation comprising at least one probiotic strain belonging to the genus Bacillus megaterium, and a polyunsaturated fatty acid component comprising at least one omega-3 or omega-6 fatty acid selected from eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (ARA), alpha linolenic acid, stearidonic acid, eicosatetraenoic acid, docosapentaenoic acid, linoleic acid, γ-linolenic acid, wherein the polyunsaturated fatty acid component comprises an omega-3 or omega-6 fatty acid salt. The invention further relates to use of the inventive preparation as a feed or food supplement, pharmaceutical product, feed-or foodstuff compositions and for topical applications.
Patent AU-2019412555-A1 (AU)
Title: Pet foods comprising gravy topping comprising methylcellulose and methods of making such pet foods
Inventor: ROUANET LAURENT
IPC: A23K20/163
Filed: 2019-12-20
Abstract: A multi-layered pet food can contain a first edible composition that is a gravy comprising methylcellulose; and a second edible composition having a flat upper surface against which the gravy is positioned. A method of preparing a multi-layered pet food can include: preparing a first edible composition that is a gravy at a first temperature, the gravy comprising methylcellulose; filling the gravy into a container; heating the gravy in the container to a second temperature to jellify the gravy; and filling a second edible composition into and on top of the first layer. The multi-layered pet food can be administered to a pet such as a companion animal.
Patent AU-2020200532-A1 (AU)
Title: Pregelatinized starch with mid-range viscosity, and product, slurry and methods related thereto
Inventor: SANG YIJUN
IPC: C08B30/14
Filed: 2020-01-24
Abstract: Disclosed are product (e.g., panels), slurry, and methods relating to a pregelatinized starch having a mid-range viscosity (i.e., from about 20 centipoise to about 700 centipoise), and an extruded pregelatinized starch.
Patent AU-2020202049-A1 (AU)
Title: Improvements in structural steel lintels
Inventor: GOLLEDGE MALCOLM ALEXANDER
IPC: E04C3/02
Filed: 2020-03-22
Abstract: A structural lintel 10 is similarly shaped as an I-beam having a horizontal lower (or bottom) 
flange 12, a horizontal upper (or top) flange 13 and a vertical web 14 extending 
therebetween. The flanges 12 and 13 and the web 14 form spaces 19a and 19b, at respective 
5 lateral sides of the web 14. The upper flange 13 is narrower in width than the lower flange 
12. The depth of the lintel 10 is determined by the height of the web 14. The height of the 
web 14 is chosen such that the internal depth, being the distance between the facing internal 
surfaces 12i and 13i of the lower flange 12 and the upper flange 13 is equal to: 
Number of brick courses (N) * Depth of each brick in mm (D)+ 
0 (N-1) * Mortar Course Thickness in mm (M) 
Where N>2
94 
83 
92 82 
10 
13 
13i X3i 
17 
14 -19a- -19b
17 
12i 12i 
12 9
Patent AU-2020203795-A1 (AU)
Title: Baby Feeding Cover
Inventor: DOWNIE KATE MAREE
IPC: A41D1/215
Filed: 2020-06-09
Abstract: A baby feeding cover (10) comprising a flexible sheet (12) and a frame (14) 
secured to the flexible sheet (12). The frame (14) is deformable such that the 
5 shape of the frame (14) and the attached flexible sheet (12) can be altered by 
bending the frame (14) between a planar configuration and one or more curved 
configurations.  
10
Patent AU-2020204679-A1 (AU)
Title: Gene therapy constructs for treating wilson disease
Inventor: LIVINGSTON CHRISTINE
IPC: C12N15/86
Filed: 2020-01-03
Abstract: This application relates to adeno-associated viral vectors encoding a truncated yet functional ATP7B for use in gene therapy for treating Wilson disease (WD). The truncated ATP7B described herein has several advantages over the wild-type ATP7B such as higher efficacy and improved manufacturing yield.
Patent AU-2020205535-A1 (AU)
Title: Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases
Inventor: YAMADA KEN-ICHI
IPC: A61P27/02
Filed: 2020-01-09
Abstract: The present invention provides: a pharmaceutical composition that is to be intraocularly or orally administered for preventing or treating a retinal disease (e.g., age-related macular degeneration) of a patient who needs to be treated, or inhibiting the progression of the disease, and that contains a pharmaceutically-acceptable carrier and an effective amount of at least one compound selected from the group consisting of apomorphine, eseroline, ethoxyquin, methyldopa, olanzapine, indapamide, and the like; and a method.
Patent AU-2020211456-A1 (AU)
Title: Compositions and methods for stimulating natural killer cells
Inventor: COPIK ALICJA
IPC: C07K14/705
Filed: 2020-01-24
Abstract: Compositions and methods for stimulating NK cell expansion and cytotoxicity are described. Therapeutic compositions and methods using expanded and stimulated NK cells are described.
Patent AU-2020217477-A1 (AU)
Title: A lift and tilt mechanism and a tilt system
Inventor: CHRISTENSEN HANS BALLE
IPC: B66F7/22
Filed: 2020-01-31
Abstract: A lift and tilt mechanism(1) is disclosed, comprising a base frame (10) and an upper lever arm (2) rotatably connected to each other by a lower lever arm (3) and a control rod (4),wherein a rotating arm (6) is rotatably connected to an upper lever arm (2), a torque arm (9) is rotatably connected to a lower lever arm (3), and the rotating arm (6) and the torque arm (9) are rotatably connected to each other, and wherein a power source(8) is rotatably connected to the upper lever arm (2) and directly or indirectly to the connection joint (19) for the rotating arm (6) and the torque arm (9), in such a way that an extension of the length of the power source (8) causes its suspension point (11) on the upper lever arm (2) to move in an substantially vertically direction, whereby the upper lever arm (2) is tilted towards a more upright position. Furthermore, a tilt system (21) comprising such a mechanism (1) is disclosed.
Patent AU-2020231194-A1 (AU)
Title: T cell receptors and methods of use thereof
Inventor: HIRANO NAOTO
IPC: C07K19/00
Filed: 2020-03-03
Abstract: The present disclosure is directed recombinant T cell receptors capable of binding a gp100 epitope and nucleic acid molecules encoding the same. In some embodiments, the nucleic acid molecules further comprise a second nucleotide sequence, wherein the second nucleotide sequence or the polypeptide encoded by the second nucleotide sequence inhibits the expression of an endogenous TCR. Other aspects of the disclosure are directed to vectors comprising the nucleic acid molecule and cells comprising the recombinant TCR, the nucleic acid molecule, or the vector. Still other aspects of the disclosure are directed to methods of using the same. In some embodiments, the methods comprise treating a cancer in a subject in need thereof.
Patent AU-2020265813-A1 (AU)
Title: Inhaler system
Inventor: MILTON-EDWARDS MARK
IPC: A61M15/00
Filed: 2020-04-30
Abstract: Provided is a system for determining a probability (or likelihood) of a respiratory disease exacerbation in a subject. The system comprises an inhaler arrangement for delivering a medicament to the subject. The medicament may be, for example, a rescue medicament or a maintenance medicament. The inhaler arrangement has a use-detection system configured to determine an inhalation performed by the subject using the inhaler arrangement. A sensor system is configured to measure a parameter relating to airflow during the inhalation. A user interface enables user-input of an indication of a status of the respiratory disease being experienced by the subject. A processor is configured to determine the probability of the respiratory disease exacerbation based on the recorded inhalation(s) from the use- detection system, the parameter(s) received from the sensor system, and the indication received from the user interface. Further provided is a method for determining the probability of a respiratory disease exacerbation in a subject.
Patent AU-2020270175-A1 (AU)
Title: Antibiotic cannabinoid-terpene formulations
Inventor: THOMPSON CHARLES J
IPC: A61K31/05
Filed: 2020-05-06
Abstract: Pharmaceutical formulations are provided that include at least two antibiotically active ingredients: a cannabinoid that is one or more of cannabichromene (CBC), cannabidiol (CBD) and/or cannabigerol (CBG); a sesquiterpene that is one or both of a-humulene and/or β-caryophyllene; and a lipopeptide antibiotic that is daptomycin or an analogue thereof. The antibiotically active ingredients may be provided in relative amounts that amplify their individual activities, including amounts that are synergistically effective in an assay to inhibit growth and/or reproduction of an
Patent AU-2020270499-A1 (AU)
Title: Ex vivo organ care system
Inventor: HASSANEIN WALEED H
IPC: A01N1/02
Filed: 2020-11-18
Abstract: The invention generally relates to systems, methods, and devices for ex vivo 
organ care. More particularly, in various embodiments, the invention relates to caring 
for a liver ex vivo at physiologic or near-physiologic conditions.
Patent AU-2020284267-A1 (AU)
Title: Absorbent pads and garments
Inventor: TRIADO PETER JULIAN
IPC: A61F13/475
Filed: 2020-05-21
Abstract: A pad 1, for a garment, comprising a body 3 and capping 5. The body has a front, a rear and a periphery and comprises one or more absorbent layers 3b, 3c, for absorbing liquid and a gas-permeable barrier 3d overlying the one or more absorbent layers to block the liquid. The capping runs along, and caps, at least a portion of the periphery to block the liquid. The capping comprises a front portion 5c overlying the front, a rear portion 5b overlying the rear, and a mounting portion 5d, projecting away from the body, for mounting the pad.
Patent AU-2020285655-A1 (AU)
Title: Flexible seed extension for hash table genomic mapping
Inventor: RUEHLE MICHAEL
IPC: C12Q1/6869
Filed: 2020-05-22
Abstract: Methods, systems, and apparatuses, including computer programs for generating and using a hash table configured to improve mapping of reads are disclosed that include obtaining a first seed of K nucleotides from a reference sequence, generating a seed extension tree having a nodes, wherein each node of the nodes corresponds to (i) an extended seed that is an extension of the first seed and has a nucleotide length of K* and (ii) one or more locations, in a seed extension table, that include data describing reference sequence locations that match the extended seed, and for each node: storing interval information at a location of the hash table that corresponds to an index key for the extended seed, wherein the interval information references one or more locations in the seed extension table that include reference sequence locations that match the extended seed associated with the node.
Patent AU-2020286768-A1 (AU)
Title: Bioactive peptides and compositions comprising them
Inventor: ERRANTE FOSCA
IPC: C07K5/103
Filed: 2020-06-05
Abstract: The present invention relates to bioactive peptides and to the cosmeceutical compositions comprising them, useful for the prevention and treatment of the signs of skin aging, such as wrinkles, fine lines and loss of firmness and elasticity of the skin, thanks to their efficacy in the protection of the dermal collagen.
Patent AU-2020295504-A1 (AU)
Title: Probiotic and chemical control of biofilms
Inventor: LI XIAOBAO
IPC: A01N59/00
Filed: 2020-06-19
Abstract: A method of controlling a biofilm comprises contacting the biofilm with probiotic species and contacting the biofilm with chemical disinfectant. The biofilm may be contacted with the probiotic species and the chemical disinfectant simultaneously or sequentially. The method provides a higher reduction in the amount of at least one microbial species in the biofilm, compared to a similar method applying only the chemical disinfectant. Furthermore, the method may provide an unexpected synergy between the probiotic species and the chemical disinfectant in controlling the biolfilm.
Patent AU-2020330235-A1 (AU)
Title: Discharging control method and charging control method for rechargeable battery, and rechargeable battery
Inventor: LI SONG
IPC: H01M10/44
Filed: 2020-08-12
Abstract: A discharging control method and a charging control method for a rechargeable battery (100), and the rechargeable battery (100). An electric system of the rechargeable battery (100) comprises a lithium ion cell (200) and a discharging control circuit (312), and may also comprise a charging control circuit (311); a positive electrode (210) of the lithium ion cell (200) is electrically connected to a common ground end (GND) of the charging and/or discharging control circuit (311, 312), so that the common ground end (GND) serves as a positive electrode (P) of the charging input and/or discharging output of the rechargeable battery (100); a negative electrode (220) of the lithium ion cell (200) is electrically connected to an output end of the charging control circuit (311) and an input end of the discharging control circuit (312); and the input end of the charging control circuit (311) and the output end of the discharging control circuit (312) are electrically connected to a negative electrode (N) of the rechargeable battery (100). The rechargeable battery (100) discharges externally by controlling the voltage of the negative electrode (220) of the lithium ion cell (200), and charges the lithium ion cell (200) by controlling the voltage and/or current of the negative electrode (N) of the rechargeable battery (100), so that the structure of the rechargeable battery (100) is simplified, more space is left for the lithium ion cell (200), and the volumetric specific energy of the lithium ion cell (200) is improved.
Patent AU-2020360144-A1 (AU)
Title: Track chain components with hardface overlay
Inventor: RATHOD CHANDRASEN R
IPC: B62D55/21
Filed: 2020-09-17
Abstract: A steel track chain component (162, 164, 166, 168, 202, 204), such as a track bushing (204), may be formed with a carburized portion (404), a hardface portion (412), and a core portion (410). The core portion (410) may be softer than the carburized portion (404), which in turn, may be softer than the hardface portion (412). This configuration of the various portions of the component (162, 164, 166, 168, 202, 204) may allow for relatively high wear resistance of the component (162, 164, 166, 168, 202, 204), as well as toughness. The core portion (410) may be mostly ferrite crystal structure, while the carburized portion (412) and the hardface portion (412) may include martensitic and/or austenitic crystal structure. The carburized portion (412) may be formed by carburizing the track chain component (162, 164, 166, 168, 202, 204) in a heated and carbon rich environment. The hardface portion (412) may be formed by welding a hardface alloy over at least a portion of the carburized portion (404).
Patent AU-2020390992-A1 (AU)
Title: Crystalline form of nitrogen-containing tricyclic compound and use thereof
Inventor: SHAN YUEFENG
IPC: A61P13/12
Filed: 2020-11-27
Abstract: A crystalline form A of a nitrogen-containing tricyclic compound shown in formula (I), a pharmaceutical composition comprising the crystalline form A, and the use of the crystalline form A or the pharmaceutical composition in the preparation of a medication for preventing, treating, or relieving an FXR-mediated disease of a patient.
Patent AU-2020417241-A1 (AU)
Title: Individualized vaccines for cancer treatment and prevention
Inventor: CHANAN-KHAN ASHER ALBAN
IPC: A61K39/00
Filed: 2020-12-29
Abstract: The present invention includes a method of preparing apoptotic bodies from a tumour and immunogenic compositions thereof. The method of preparation comprises: obtaining human tumour cells from a subject, inducing apoptosis of the human tumour cells with a drug or a physical treatment, and collecting apoptotic bodies from the apoptotic human tumour cells by centrifugation. The method comprises two centrifugation steps, low-speed at 50 g for 5 minutes to pellet cells, followed by high-speed centrifugation of the obtained supernatant at 3,000 g for 8 minutes to pellet apoptotic bodies. The purity of the apoptotic bodies (also referred to as immunogenic Tumor Apoptotic Bodies (TABi)) was determined by FACS to be 82.22%.
Patent AU-2020442210-A1 (AU)
Title: A filter diaphragm for a horizontal plate and frame -type filter, such as a tower press
Inventor: MUSTAKANGAS MIRVA
IPC: B01D25/164
Filed: 2020-04-17
Abstract: A filter diaphragm (1) for a horizontal plate and frame -type filter, such as a tower press, comprising a sheet like body (2) and at least on a filter plate -facing side (1d) thereof, a continuous seal bead (3). The seal bead comprises an inner seal lip (4) on a lateral inside (1a) of the seal bead (3) and an outer seal lip (5) surrounding the inner seal lip (4) on a lateral outside (1b) of the seal bead (1). The outer seal lip (5) is elevated from the inner seal lip (4) in a vertical direction perpendicular to a general plane defined by the diaphragm (1).
Patent AU-2020442693-A1 (AU)
Title: Magnetic biogenic manganese oxide absorption material, preparation method therefor, and use thereof
Inventor: WANG HUAWEI
IPC: B01J20/28
Filed: 2020-05-22
Abstract: Provided are a magnetic biogenic manganese oxide absorption material, a preparation method therefor, and a use thereof. The method comprises: selecting Pseudomonas putida capable of inducing the production of biogenic manganese oxide, and subjecting biogenic manganese oxide to a magnetic modification via a Schiff base reaction to produce the magnetic biogenic manganese oxide absorption material for treatment of arsenic-containing wastewater.
Patent WO-2022120417-A1 (WO)
Inventor: KAZAL KARL
IPC: G06Q40/02
Filed: 2021-12-07
Abstract: La présente invention concerne des systèmes et des procédés pour traiter atomiquement des transactions contenant des paiements d'obligation. Selon un aspect, le système automatisé calcule et traite automatiquement des paiements pour des transactions entre à la fois les parties principales et avec les tiers. Le tiers auquel une obligation est due peut avoir une visibilité sur les calculs et les processus de paiement. Le système est conçu pour maintenir l'atomicité des transactions financières, y compris les paiements dus au tiers suite à la transaction. Pendant le traitement atomique de la transaction, des paiements d'obligation au tiers peuvent être traités grâce à un compte d'obligations qui suit un solde d'obligations qu'une partie donnée d'une transaction doit au tiers, ce qui garantit que le tiers reçoit les paiements appropriés.
Patent AU-2021200035-A1 (AU)
Title: Stable formulations of immunoglobulin single variable domains and uses thereof
Inventor: MEYVIS YVES
IPC: A61P9/10
Filed: 2021-01-05
Abstract: The present invention relates to stable formulations of polypeptides, e.g. immunoglobulin single 
variable domains, in particular immunoglobulin single variable domains directed against von 
Willebrand Factor (vWF). The invention provides formulations which are stable upon storage for 
5 prolonged periods of time and over a broad range of temperatures. The formulations of the 
invention ensure a high stability of the polypeptide, allowing multiple freeze-thaw cycles without 
chemical or physical deterioration, and provide stability in relation to mechanical stress, such as 
shake, shear or stir stress. They are suitable for pharmaceutical and diagnostic preparations and 
compatible with pharmaceutically acceptable diluents.